Antiretroviral therapy in HIV-2-infected patients
- 1 July 2003
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in AIDS
- Vol. 17, S49-S54
- https://doi.org/10.1097/00002030-200317003-00007
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Dual Infection with Human Immunodeficiency Virus Type 1 and Type 2: Impact on HIV Type 1 Viral Load and Immune Activation Markers in HIV-Seropositive Female Sex Workers in Abidjan, Ivory CoastAIDS Research and Human Retroviruses, 2000
- Antiretroviral Therapy in Patients with Dual Infection with Human Immunodeficiency Virus Types 1 and 2New England Journal of Medicine, 2000
- Predominance of Human Immunodeficiency Virus Type 2 Subtype B in Abidjan, Ivory CoastAIDS Research and Human Retroviruses, 1999
- Genetic Analysis of Human Immunodeficiency Virus in Abidjan, Ivory Coast Reveals Predominance of HIV Type 1 Subtype A and Introduction of Subtype GAIDS Research and Human Retroviruses, 1999
- Emergence of Multi‐Dideoxynucleoside‐Resistant Human Immunodeficiency Virus Type 1 Variants, Viral Sequence Variation, and Disease Progression in Patients Receiving Antiretroviral ChemotherapyThe Journal of Infectious Diseases, 1998
- In vivo emergence of HIV-1 variants resistant to multiple protease inhibitorsNature, 1995
- Locations of Anti-AIDS Drug Binding Sites and Resistance Mutations in the Three-dimensional Structure of HIV-1 Reverse Transcriptase: Implications for Mechanisms of Drug Inhibition and ResistanceJournal of Molecular Biology, 1994
- Reduced Rate of Disease Development After HIV-2 Infection as Compared to HIV-1Science, 1994
- Cellular and plasma viral load in patients infected with HIV-2AIDS, 1993
- Ordered Appearance of Zidovudine Resistance Mutations during Treatment of 18 Human Immunodeficiency Virus-Positive SubjectsThe Journal of Infectious Diseases, 1992